299 related articles for article (PubMed ID: 18418511)
1. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
Tan RM; Chng SM; Seow WT; Wong J; Lim CC
Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya disease in children.
Takanashi J
Brain Dev; 2011 Mar; 33(3):229-34. PubMed ID: 20932697
[TBL] [Abstract][Full Text] [Related]
3. Surgical Treatment for Patients with Moyamoya Syndrome and Type 1 Neurofibromatosis.
Porras JL; Yang W; Garzon-Muvdi T; Xu R; Blakeley J; Belzberg A; Caplan JM; Khalid S; Colby GP; Coon AL; Tamargo RJ; Ahn ES; Huang J
World Neurosurg; 2017 Mar; 99():19-25. PubMed ID: 27876659
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromatosis type 1 association with moyamoya disease.
Koc F; Yerdelen D; Koc Z
Int J Neurosci; 2008 Aug; 118(8):1157-63. PubMed ID: 18576213
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease.
Fujiwara H; Momoshima S; Kuribayashi S
Eur J Radiol; 2005 Aug; 55(2):224-30. PubMed ID: 16036151
[TBL] [Abstract][Full Text] [Related]
6. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
[TBL] [Abstract][Full Text] [Related]
7. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
8. Perfusion MRI abnormalities in the absence of diffusion changes in a case of moyamoya-like syndrome in neurofibromatosis type 1.
El-Koussy M; Lövblad KO; Steinlin M; Kiefer C; Schroth G
Neuroradiology; 2002 Nov; 44(11):938-41. PubMed ID: 12428131
[TBL] [Abstract][Full Text] [Related]
9. Ophthalmic artery ischemic syndrome associated with neurofibromatosis and moyamoya syndrome.
Witmer MT; Levy R; Yohay K; Kiss S
JAMA Ophthalmol; 2013 Apr; 131(4):538-9. PubMed ID: 23430230
[No Abstract] [Full Text] [Related]
10. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
[TBL] [Abstract][Full Text] [Related]
11. Segmental neurofibromatosis type 1 (NF1) associated with Cobb syndrome: case report.
Pascual-Castroviejo I; Pascual-Pascual SI; Viaño J
Neuropediatrics; 2008 Dec; 39(6):341-3. PubMed ID: 19568998
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and long-term outcomes of moyamoya syndrome associated with neurofibromatosis type 1.
Han C; Yang WZ; Zhang HT; Ye T; Duan L
J Clin Neurosci; 2015 Feb; 22(2):286-90. PubMed ID: 25443089
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
[TBL] [Abstract][Full Text] [Related]
15. Moyamoya syndrome and neurofibromatosis type 1.
Vargiami E; Sapountzi E; Samakovitis D; Batzios S; Kyriazi M; Anastasiou A; Zafeiriou DI
Ital J Pediatr; 2014 Jun; 40():59. PubMed ID: 24952383
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological consideration of medullary streaks on FLAIR imaging in pediatric moyamoya disease.
Suzuki H; Mikami T; Kuribara T; Yoshifuji K; Komatsu K; Akiyama Y; Ohnishi H; Houkin K; Mikuni N
J Neurosurg Pediatr; 2017 May; 19(5):560-566. PubMed ID: 28291429
[TBL] [Abstract][Full Text] [Related]
17. Moyamoya disease in a child with neurofibromatosis type-1.
Kwong KL; Wong YC
J Paediatr Child Health; 1999 Feb; 35(1):108-9. PubMed ID: 10234650
[No Abstract] [Full Text] [Related]
18. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.
Denckla MB; Hofman K; Mazzocco MM; Melhem E; Reiss AL; Bryan RN; Harris EL; Lee J; Cox CS; Schuerholz LJ
Am J Med Genet; 1996 Feb; 67(1):98-102. PubMed ID: 8678124
[TBL] [Abstract][Full Text] [Related]
19. Unidentified bright objects in neurofibromatosis type 1: conventional MRI in the follow-up and correlation of microstructural lesions on diffusion tensor images.
Ferraz-Filho JR; José da Rocha A; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino-Bertelli EC
Eur J Paediatr Neurol; 2012 Jan; 16(1):42-7. PubMed ID: 22088602
[TBL] [Abstract][Full Text] [Related]
20. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S
Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
